Dopamine receptor D4 (DRD) polymorphisms with reduced functional potency intensify atrophy in syndrome-specific sites of frontotemporal dementia

Paul Butler, Winston Chiong, David C. Perry, Zachary Miller, Efstathios D. Gennatas, Jesse A. Brown, Lorenzo Pasquini, Anna Karydas, Deepika Dokuru, Giovanni Coppola, Virginia E. Sturm, Adam L. Boxer, Maria Luisa Gorno‐Tempini, Howard J. Rosen, Joel H. Kramer, Bruce L. Miller, William W. SeeleyNeuroImage 2019 · DOI

Abstract

We conclude that DRD<sub>4</sub> polymorphisms with reduced functional potency exacerbate neuronal injury in sites of higher receptor density, which intersect with syndrome-specific regions undergoing neurodegeneration in FTD.
BibTeX
@inproceedings{butler2019dopamine,
  author = {Paul Butler and Winston Chiong and David C. Perry and Zachary Miller and Efstathios D. Gennatas and Jesse A. Brown and Lorenzo Pasquini and Anna Karydas and Deepika Dokuru and Giovanni Coppola and Virginia E. Sturm and Adam L. Boxer and Maria Luisa Gorno‐Tempini and Howard J. Rosen and Joel H. Kramer and Bruce L. Miller and William W. Seeley},
  title = {{Dopamine receptor D4 (DRD) polymorphisms with reduced functional potency intensify atrophy in syndrome-specific sites of frontotemporal dementia}},
  booktitle = {NeuroImage},
  year = {2019},
  doi = {10.1016/j.nicl.2019.101822},
}

Loading related content...

Figure